M&A Deal Summary

Bristol-Myers Squibb Acquires Dupont Pharmaceuticals Company

On October 2, 2001, Bristol-Myers Squibb acquired life science company Dupont Pharmaceuticals Company from DuPont for 7.8B USD

Acquisition Highlights
  • This is Bristol-Myers Squibb’s 1st transaction in the Life Science sector.
  • This is Bristol-Myers Squibb’s 4th largest (disclosed) transaction.
  • This is Bristol-Myers Squibb’s 1st transaction in the United States.
  • This is Bristol-Myers Squibb’s 1st transaction in Delaware.

M&A Deal Summary

Date 2001-10-02
Target Dupont Pharmaceuticals Company
Sector Life Science
Buyer(s) Bristol-Myers Squibb
Sellers(s) DuPont
Deal Type Divestiture
Deal Value 7.8B USD

Target

Dupont Pharmaceuticals Company

Wilmington, Delaware, United States
DuPont Pharmaceuticals Company is a life science company that produces a variety of drugs. These include SUSTIVA, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV/AIDS; COUMADIN, a widely-used oral blood anticoagulant; and CARDIOLITE(R), a cardiovascular medical imaging agent. DuPont Pharmaceuticals Company was formed in 1991 and is based in Wilmington, Delaware.

Search 191,421 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bristol-Myers Squibb

New York, New York, United States

website


Category Company
Founded 1887
Sector Life Science
Employees32,200
Revenue 46.2B USD (2022)
DESCRIPTION

Bristol-Myers Squibb is a life science company engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. The Company's pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from biological processes. The majority of Bristol-Myers Squibb's revenue comes from products in the following therapeutic classes: cardiovascular; virology, including human immunodeficiency virus (HIV) infection; oncology; neuroscience; immunoscience; and metabolics. Bristol-Myers Squibb was incorporated in 1887 and is based in New York City.


DEAL STATS #
Overall 1 of 23
Sector (Life Science) 1 of 23
Type (Divestiture) 1 of 1
State (Delaware) 1 of 1
Country (United States) 1 of 20
Year (2001) 1 of 1
Size (of disclosed) 4 of 19
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-08-07 Zimmer Biomet Holdings

Warsaw, Indiana, United States

Zimmer Biomet Holdings is a designer, developer, manufacturer of orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer Biomet Holdings was founded in 1927 and is based in Warsaw, Indiana.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-09-27 Adnexus Therapeutics

Waltham, Massachusetts, United States

Adnexus Therapeutics is a developer of a new therapeutic class of biologics called Adnectins. Adnexus Therapeutics was founded in 2002 and is based in Waltham, Massachusetts.

Buy $430M

Seller(S) 1

SELLER

DuPont

Wilmington, Delaware, United States

website


Category Company
Founded 1802
Sector Chemicals
Employees23,000
Revenue 13.0B USD (2022)
DESCRIPTION
Entrance to DuPont's corporate headquarters in Wilmington, Delaware.
Entrance to DuPont's corporate headquarters in Wilmington, Delaware.

DuPont is a global chemicals provider and is involved across a range of disciplines, including agriculture and industrial biotechnology, chemistry, biology, materials science and manufacturing. DuPont operates globally and offers a wide range of innovative products and services for markets including agriculture and food, building and construction, electronics and communications, general industrial, and transportation. DuPont is based in Wilmington, Delaware.


DEAL STATS #
Overall 3 of 20
Sector (Life Science) 1 of 2
Type (Divestiture) 2 of 17
State (Delaware) 1 of 9
Country (United States) 3 of 18
Year (2001) 1 of 1
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-03-16 Pioneer Hi-Bred International

Johnston, Iowa, United States

Pioneer Hi-Bred International, Inc., we nurture relationships to build mutually successful outcomes by listening to customers, walking their fields and sharing technical resources to develop individualized solutions. Pioneer is working on new traits and using new technologies that will help bring farmers the greatest value and ultimately benefit the entire food and energy value chain.

Buy $7.7B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-01-01 Solae

St. Louis, Missouri, United States

Solae, LLC is a leader in developing soy-based ingredients for nutritious, great-tasting products. Solae provides solutions that deliver a unique combination of functional, nutritional, economical and sustainable benefits to our customers. Headquartered in St. Louis, Missouri, USA, the company was formed through a joint venture between DuPont and Bunge in 2003.

Buy -